Federal Practitioner

IL-17 inhibitor approved in Europe for hidradenitis suppurativa

June 5, 2023

Dermatology

What’s in a drug name?

June 5, 2023

Business of Medicine

New CLL meds: Improved survival rates, 1990-2018

June 5, 2023

Hematologic Malignancies

Prenatal sleep problems, depression linked to poorer outcomes

June 5, 2023

We may need a new defense against new COVID variants

June 5, 2023

COVID-19 Updates

COVID nonvaccination linked with avoidable hospitalizations

June 5, 2023

COVID-19 Updates

Mindfulness-based stress reduction program benefits MS patients

June 5, 2023

Dupilumab outcomes stable at end of open label atopic dermatitis study

June 5, 2023

Dermatology

The new vaccine your patients may not want

June 5, 2023

EULAR systemic sclerosis recommendations now include immunosuppressants

June 5, 2023

URAT1 inhibitor shows ‘substantial’ uric acid reduction in phase 2 gout trial

June 5, 2023

Oral drug for brain tumor could change treatment landscape

June 4, 2023

Up-front pembro plus chemo boost survival in cervical cancer

June 4, 2023

Immuno-oncology

Ribociclib forestalls recurrence also in early breast cancer

June 4, 2023

Breast Cancer

‘Huge step forward’ in advanced ovarian cancer

June 4, 2023

Immuno-oncology